Navigation Links
Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM)
Date:10/20/2009

of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind.

PulmoScience was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by Pulmo BioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and exciting technology, to fund necessary trials, and to bring the products to market.

PulmoScience believes that the market for its product candidates is worth in excess of $500 million per annum and that, provided Regulatory Approval is achieved, the safety and efficacy of its products could allow it to dominate that market.

About PulmoBind

PulmoBind uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind will offer when compared to the current incumbent nuclear medicine based technology for the diagnosis of Pulmonary Embolism. In addition, early indications are that PulmoBind could be highly effective in the early stage diagnosis of Pulmonary Hypertension, a condition for which there is no current front line diagnostic test. The addressable market for the pro
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators
2. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
3. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
4. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
5. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
6. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
7. Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
8. APTA Supports Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
9. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
10. Pulmo BioTech Inc. Completes Bio-Distribution Studies
11. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from ... session of a silicone treatment for gluteus augmentation at Cuerpos ... performed by a mystery Venezuelan doctor in a center that ... Bernabe Vazquez of Bayshore Cosmetic Surgery , women suffering ... are not board certified is more common than people think. ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... People with HIV are more likely to keep their ... if they feel their physician listens, explains things ... a "case," new Johns Hopkins research suggests. , "If ... to them, they feel that doctor has their best ... follow medical advice," says study leader Tabor E. Flickinger, ...
(Date:6/18/2013)... of investigators co-led by Weill Cornell Medical College is ... research, similar to the kind of risk and benefit ... no dynamic research framework to systematically detect devices and ... may even be harmful," says co-lead investigator Dr. Art ... the June 18 issue of the British Medical ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... ... SRI International, an independent nonprofit research and development institute, announced ... its Center for Health Sciences. This new SRI group of neuroscientists and ... of funding from the National Institutes of Health (NIH), including the ...
... , LAVAL, QC and ... Inc. (TSX: DDS; NASDAQ: DDSS ) today announced the closing ... units were sold at a price of US$1.70 per ... were US$18,150,000 after deducting underwriting discounts and commissions, and ...
... how human genes interact with their environment to boost ... edition of the American Journal of Human Genetics ... for specific gene variants linked to human diseases can ... genes and environmental factors influence common human diseases like ...
... the battlefield, a new UCLA study of U.S. Civil War ... units characterized by a strong esprit de corps were much ... heart condition than veterans from less cohesive companies, two UCLA ... expect your buddy to have your back," said Dora Kosta, ...
... ... of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft Technology Corp. , the trusted ... provider of extreme-scale grid computing software and services. Carahsoft is placing Parabon ...
... ... team, names Estelle Cummings as Area Vice-President of Sales , ... Cambridge, MD (PRWEB) February 18, 2010 -- ... V.P. of Sales for the CCBsure®, technology program . Cummings oversees new ...
Cached Medicine News:Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 2Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 3Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 4Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 5Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 6Health News:Labopharm announces closing of US$20 million public offering of units 2Health News:Labopharm announces closing of US$20 million public offering of units 3Health News:UCLA study reveals how genes interact with their environment to cause disease 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 3Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 4Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:CCBsure Names New Area Vice-President of Sales 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: